malondialdehyde has been researched along with orlistat in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coskun, S; Jale, C; Sarac, M; Serdar, A; Serdar, Z; Yesilbursa, D | 1 |
Karatas, F; Kelestimur, H; Ozcelik, O; Ozkan, Y | 1 |
Audikovszky, M; Fülöp, P; Harangi, M; Illyés, L; Katona, E; Katona, EM; Pados, G; Paragh, G; Seres, I; Winkler, G | 1 |
3 trial(s) available for malondialdehyde and orlistat
Article | Year |
---|---|
Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels.
Topics: Adult; Biomarkers; Body Mass Index; Case-Control Studies; Diet, Reducing; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Obesity; Orlistat | 2005 |
Exercise training as an adjunct to orlistat therapy reduces oxidative stress in obese subjects.
Topics: Adult; Anti-Obesity Agents; Antioxidants; Body Composition; Body Weight; Exercise; Female; Humans; Lactones; Lipid Peroxidation; Male; Malondialdehyde; Obesity; Orlistat; Oxidative Stress; Vitamin A; Vitamin E; Weight Loss | 2005 |
Orlistat increases serum paraoxonase activity in obese patients.
Topics: Adult; Aged; Anti-Obesity Agents; Aryldialkylphosphatase; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Lactones; Lipid Peroxidation; Longitudinal Studies; Male; Malondialdehyde; Middle Aged; Obesity; Orlistat | 2007 |